Temozolomide
替莫唑胺
Report date: 2026/04/24 20:01:59
NME
Base Information
Drug NameTemozolomide
Drug Alias Name +[15]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[53]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1999/01/26
Country/Territory +[26]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A
Develop Information
Active CompaniesCross Cancer InstituteUniversity Of California San FranciscoDouble Bond Pharmaceutical AB +[19]
Inactive CompaniesNovocure LtdSentoclone AbInstituto Canario De Investigación Del Cáncer +[55]
Active Indications +[17]
Inactive Indications +[36]